ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Sanofi · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
autoimmune-diseaseschronicnervous-systemneurological-disorders
chronic inflammatory demyelinating polyradiculoneuropathy, polyneuropathy, inflammatory demyelinating, chronic, autoimmune diseases, neurologic, autoimmune disorders, nervous system, peripheral nerves disease, nervous system diseases, neurologic disorders, neurological disorders, complement inhibitor, complement inhibitors, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 812759
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.